The WHO also hopes to convene global experts to help research leaders and policymakers fill knowledge gaps on issues in their nations that will have broad practical impact. For example, cost-effective interventions for non-communicable diseases would promote health and address leading causes of death. What policies increase the consumption of fruits and vegetables by people in poverty? Where physicians are scarce, can nurses help people with diabetes to manage their condition, using decision-support systems on mobile phones? The goal is for scientists from the global south to truly take the driver's seat, so that questions and insights will address countries' needs and deliver tangible results.
We anticipate that this research will generalize to help strengthen health systems. For example, how best can digital-health tools assist front-line workers in providing quality services? Can real-time data visualization in a capital city recognize a hepatitis outbreak in one province, or a shortage of malaria bednets in another? How can countries learn to use their data to improve health systems? Another task is to ensure that advances in technology are matched with the most pressing needs. For example, mobile phones allow information to flow rapidly to remote settings, and so enable the provision of certain health services without face-to-face visits. Artificial intelligence might do the same, but will require a regulatory framework. Medicines and diagnostics are not rolled out until their relative risks and benefits have been assessed. Health-care software should have similar requirements.
The WHO has two unique advantages for helping to decide which frameworks should be applied to emerging technology: its high credibility and its convening power. New technologies offer endless possibilities, from machine learning for disease prediction to gene drives in mosquitoes to stop malaria. They also demand broad societal discussion of ethics, equity, justice, risks, benefits and appropriate limits, especially when technologies could harm the most vulnerable. Several experts have called for the WHO to set up an observatory or registry to record ongoing clinical studies involving therapeutic gene editing of human cells or embryos, and to collect input from the public and diverse experts to propose a global regulatory framework.
Achieving these goals for the science division will be challenging. The WHO has a surprisingly small budget for its outsized role, and must work hard to secure consensus and cooperation from funders and member countries. However, all agree on the urgency of these tasks, and the need to come together and realize them. Greater coordination of science activities within the WHO will help to make that happen. WORLD VIEWA personal take on events
